Anove LogoAnove LogoExplAIn
MapsAI frontrunners
Back to Directory

Aletta

by Vitestro

AI Application
Low Confidence

Aletta is an autonomous robotic phlebotomy device that draws diagnostic blood samples in hospital blood-collection departments, for patients aged 16 and over. The vendor says it uses near-infrared imaging, ultrasound and Doppler to find a suitable vein and tell veins from arteries, and AI guidance with robotics to position and insert the needle; it then fills the sample tubes and applies a bandage, using a new sterile needle for each patient. A trained phlebotomist decides which patients are suitable, oversees the procedure and can supervise up to three devices, and the patient can press a stop or help button at any time. Aletta was CE-marked under the MDR in July 2024 and received FDA De Novo authorisation in August 2026; the vendor describes it as in clinical and pre-commercial use in Europe, starting with a limited release at selected hospitals. The vendor does not publish the device class or say whether any data leave the device.

Visit Website

Transparency Score

Weighted across four pillars · updated October 20, 2026

Overall grade
27% weighted
ABCDF
Model
—
Not yet assessed
Infrastructure
—
Not yet assessed

Capabilities

Vein Detection
Needle Guidance
Autonomous Blood Collection
Sample Tube Handling

Vendor Information

Complete information about the vendor/provider of this AI application

VitestroView all products →
Vitestro B.V.(Trading as: Vitestro)
Contact Information
vitestro.com
hello@vitestro.com
Registered Address
Europalaan 500, Utrecht, Utrecht, 3526 KS, NL

EU AI Act Provider Information

Verification Status:
Unverified
(Last verified: October 20, 2026)
Vitestro B.V.(Trading as: Vitestro)
Europalaan 500, Utrecht, Utrecht, 3526 KS, NL
hello@vitestro.com
Compliance Documents
CE Marking: Certified
Vitestro says Aletta is designed for patients aged 16 and over in hospital phlebotomy settings, 'may not be appropriate for every patient or every blood draw', and that suitability is decided by phlebotomy staff on site; a trained phlebotomist oversees each procedure (https://vitestro.com/faq/, read 2026-10-20). It reports more than 12,000 EU blood collections with no serious adverse events (same page). The instructions for use are not public.
Compliance & Risk

Get insights into risk by running assessments on this AI application.

Work at Vitestro? Claim this listing to correct or complete the data.

Added: October 20, 2026
Updated: October 20, 2026

Ready to manage AI applications?

Track, assess, and govern your AI applications with Anove.

Anove LogoAnove LogoAnove International B.V.

Helping organizations discover and manage AI applications responsibly. Your trusted source for AI governance and compliance.

Quick Links

  • Browse Directory
  • FAQ
  • AI maps by industry
  • Sign In

Resources

  • Documentation
  • Status
  • Anove.ai

Terms

  • Privacy Policy
  • Terms & Conditions
  • Responsible Disclosure
  • AI Legal Notice
  • Security Policy

© 2026 Anove International B.V. All rights reserved.